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Key points 
- A meta-analysis including 63 independent datasets was conducted. 
- Use of legal supplements, perceived social norms, and positive attitudes towards doping 
were strong positive correlates of doping intentions and behaviors. 
- Morality and self-efficacy to refrain from doping were negatively associated with doping 
intentions and behaviors. 
 
Abstract 
Background: There is a growing body of empirical evidence on demographic and psycho-
social predictors of doping intentions and behaviors utilizing a variety of variables and 
conceptual models. However, to date there has been no attempt to quantitatively synthesize 
the available evidence and identify the strongest predictors of doping. 
Objectives: Using meta-analysis, we aimed to (i) determine effect sizes of psychological 
(e.g., attitudes), social-contextual factors (e.g., social norms), and demographic (e.g., sex and 
age) variables on doping intentions and use, (ii) examine variables which moderate such 
effect sizes, and (iii) test a path analysis model, using the meta-analyzed effect sizes, based 
on variables from the Theory of Planned Behavior. 
Data sources: Articles were identified from online databases, by contacting experts in the 
field, and searching the World Anti-Doping Agency website.  
Study eligibility criteria and participants:  Studies that measured doping behaviors and/or 
doping intentions, and at least one other demographic, psychological, or social-contextual 
variable were included. We identified 63 independent datasets. 
Study appraisal and synthesis method: Study information was extracted by using 
predefined data fields and taking into account study quality indicators.  A random effects 
meta-analysis was carried out, correcting for sampling and measurement error, and 
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identifying moderator variables. Path analysis was conducted on a sub-set of studies that 
utilized the Theory of Planned Behavior.  
Results: Use of legal supplements, perceived social norms, and positive attitudes towards 
doping were the strongest positive correlates of doping intentions and behaviors. In contrast, 
morality and self-efficacy to refrain from doping had the strongest negative association with 
doping intentions and behaviors. Furthermore, path analysis suggested that attitudes, 
perceived norms, and self-efficacy to refrain from doping predicted intentions to dope, and 
indirectly, doping behaviors. 
Limitations: Various meta-analyzed effect sizes were based on a small number of studies, 
which were correlational in nature. This is a limitation of the extant literature. 
Conclusions: This review identifies a number of important correlates of doping intention and 
behavior, many of which were measured via self-reports and were drawn from an extended 
theory of planned behavior framework. Future research might benefit from embracing other 
conceptual models of doping behavior and adopting experimental methodologies that will test 
some of the identified correlates in an effort to develop targeted anti-doping policies and 
programs.  
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1 Introduction 
 According to the World Anti-Doping Agency [1], doping behavior refers to the use of 
illegal performance enhancing drugs and methods to improve performance. Anti-doping rules 
and regulations in sport are founded upon the premise that doping use violates the rules of 
competition and the spirit of sport, and it can lead to health risks in users [1]. Nonetheless, 
doping behaviors are not uncommon across all levels of sport and exercise participation [2, 3]. 
In a study conducted in a gym setting, more than 10% of participants self-reported engaging 
in doping behaviors [4]. Amongst competitive bodybuilders, the figures are as high as 77.8% 
[5]. In competitive sport, the prevalence statistics are wide-ranging and appear to be 
dependent on the measurement technique employed. Questionnaire-based evidence indicates 
that approximately 10%-15% of elite and sub-elite athletes reported using doping substances 
in the past [6]. The use of indirect measures (e.g., Implicit Association Test or the 
Randomized Response Technique) indicates that the prevalence of doping use in competitive 
sport can be as high as 30% [7-9]. The Athlete Biological Passport paradigm has also 
provided estimates of the prevalence of blood doping. Analysis of samples from 2737 
international athletes provided a mean estimate of 14% for the combined sample, but sub-
population analysis highlighted wide ranging estimates from 1% to 48% [10]. All these 
figures are in stark contrast to the fact that, year on year, less than 2% of drug tests analyzed 
by WADA laboratories prove positive.  
Therefore, despite the efforts of WADA, the International Olympic Committee (IOC) 
and global sports federations, drug use in sport and exercise settings is on the rise [11] with a 
recent high profile case being that of the cyclist Lance Armstrong. The reality is that 
detection techniques are not keeping pace with developments in the pharmaceutical industry 
[12] and the need for anti-doping education is greater than ever [11]. Thus, preventive and 
educational action must be afforded greater attention and resource to reduce instances of 
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doping. Such preventative action necessitates an understanding of the psycho-social 
predictors of doping intentions and behavior. Research examining such predictors has 
significantly increased over the last decade. As such, a number of positive and negative 
correlates at the personal and socio-contextual level (e.g., achievement goal orientations, 
moral values, social norms) have been identified. In line with health-related behavior research, 
most studies in the doping field have adopted the theory of planned behavior (TPB) [13, 14] 
as a broader theoretical background to examine the psycho-social mechanisms that may lead 
to doping in sport. In this theory, behavior is viewed as a distal or proximal outcome of 1) 
intention, 2) attitude, 3) subjective norm, and 4) perceived behavioral control. Attitudes 
represent an individual’s positive or negative evaluations of performing the behavior in 
question. Subjective norms are conceptualized as the pressure that individuals perceive from 
significant others to engage (or not) in the target behavior. Perceived behavioral control 
represents one’s evaluation about their capabilities to perform the behavior. As such, it may 
reflect obstacles encountered in past behavioral performances. Attitudes, subjective norms 
and perceived behavioral control are proposed to influence behavior through their influence 
on intention to perform the behavior. Hence, intentions represent an individual’s proximal 
predictor of doping behavior.  
Researchers utilizing TPB have documented the ability of doping attitudes, perceived 
behavioral control and subjective norms to predict doping intention and self-reported doping 
behavior [e.g., 15-17]. These studies have involved a variety of populations including elite 
athletes [16], gym users [18], and adolescents [17, 19]; suggesting generalizability of findings 
across different samples and settings. Alongside the core TPB variables, researchers have 
also used constructs outside the TPB framework to predict doping intentions and behaviors. 
The extension of the TPB approach was undertaken because of a) the need to investigate 
morality issues bearing in mind that doping is considered an immoral behavior, b) recent 
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developments in TPB research in other areas of enquiry (e.g. smoking), showing that the 
addition of new constructs (i.e., descriptive norms, situational temptation) improves the 
predictive ability of the TPB model, and c) recent arguments suggesting the use of integrative 
approaches [14, 20] to incorporate distal predictors of behavior (e.g., sportspersonship, moral 
disengagement, or achievement goals in the case of doping) and demographics. As an 
example of such new approaches, Lucidi et al. [17] measured participants’ moral 
disengagement (i.e., disassociating oneself from the moral implications of one’s unethical 
actions) and showed that this variable predicted doping intentions and behaviors. Barkoukis 
et al. [21] found that athletes with high sportspersonship (e.g., prosocial attitudes and 
behaviors), autonomous motivation (i.e., motivation resulting from enjoyment or personal 
value) and mastery-oriented achievement goals (i.e., emphasis on personal improvement and 
effort) reported lower doping intentions compared to those with low sportspersonship, 
controlled motivation  (i.e., motivation resulting from pressure, social approval or feelings of 
guilt) and performance oriented achievement goals (i.e., emphasis on displaying normative 
superiority). Mixed evidence accompanies research exploring the demographic predictors of 
doping use. For instance, males, compared to females, have been found to be at a greater risk 
for doping across samples of adolescents [22] and competitive athletes [23, 24]. However, 
Wiefferink et al. [18] did not find any effects of sex or age on self-reported use of doping 
substances in a sample of gym and fitness users.  
The aforementioned findings highlight that doping use is complex and is probably 
predicted by a variety of situational and personal variables. The vast majority of studies in 
this area are correlational in design and doping behavior is self-reported. Anti-doping 
interventions from a psycho-social perspective are scarce [25]. As an exception, Elliot et al. 
[26] designed an intervention consisting of eight 45-minute meetings held during sport team 
training in US high schools. This was a peer-led intervention which did not focus exclusively 
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on doping; students engaged in cooperative learning exercises regarding healthy nutrition and 
strength training regimes, as well as the effects of legal and illegal supplements and other 
substances on performance. The intervention was sex-specific targeting different aspect of 
males’ (i.e., steroid use; project Adolescents Training and Learning to Avoid Steroids - 
ATLAS) and females’ (i.e., disordered eating behavior; project Athletes Targeting Healthy 
Exercise and Nutrition Alternatives - ATHENA) behaviors. Using a randomized control trial 
design, Elliot et al. showed that the program significantly reduced the use of recreational 
drugs and doping substances in participants one to three years after the students graduated 
from high school. However, the effect sizes found were very small. 
To date, only one systematic narrative literature review has been performed to 
synthesize the research findings in this area [25]. The authors reviewed 103 articles focusing 
on attitudes, values and beliefs towards doping, predictors and precipitating factors in anti-
doping education and prevention programs. Most included studies examined attitudes 
towards doping. Only 21 studies examined use of performance enhancing drugs and most of 
those studies examined risk factors for anabolic steroid use amongst weight lifters or body 
builders. As such, the findings from this review may not be generalizable to other populations 
and settings, and are better suited for understanding attitudes toward doping but not 
necessarily doping intention and use. By conducting a meta-analysis of existing studies, 
researchers can provide a vigorous test of theoretical frameworks utilized in the field of 
doping, by incorporating a large number of studies using different study designs and 
including participants with varying demographic backgrounds. A meta-analysis can 
accumulate, quantify, and summarize existing empirical evidence controlling for sampling 
and measurement errors which cannot be taken into account by narrative reviews. By 
quantifying the magnitude of the size of effect between variables and testing the homogeneity 
of this effect across different groups or contexts, researchers can identify key psycho-social 
Running head: PERSONAL AND PSYCHOSOCIAL PREDICTORS OF DOPING 7 
predictors of doping intention and behavior, so that resources are specifically targeted on 
these risk factors. Further, based on the results of meta-analysis, researchers may refine 
existing theoretical frameworks or develop new ones that could better explain the links 
between demographic and psychosocial variables with doping intention and behavior.  
1.1 Objectives of the Current Study 
In order to provide a statistical synthesis of research findings in the literature, we 
conducted a meta-analysis of existing studies. The first aim of this study was to identify the 
strongest psycho-social correlates (both positive and negative) of doping intentions and use 
(behaviors). The studies reporting the results of the ATLAS/ATHENA interventions were 
included in our meta-analysis; although these studies did not focus exclusively on doping, 
doping behavior was one of their outcome measures and hence they met our inclusion criteria. 
In addition to psychological (e.g., attitudes) and social-contextual factors (e.g., social norms), 
the predictive effects of demographic variables (e.g., sex and age) on doping intentions and 
behaviors were also examined. Results from intervention studies were also meta-analyzed in 
order to examine the effectiveness of anti-doping interventions by comparing the findings 
between the experimental and control arms. By conducting a meta-analysis, one can examine 
whether real effects (i.e., effects that are unlikely to be due to chance) exist between two 
variables. Moreover, the size of such effects could be calculated using a standardized metric, 
which is useful for comparison purposes.  
 The second aim of this study was to identify moderator variables (i.e., whether the 
effect size associated with the relationship between two variables varies at different levels of 
the moderator variable). Testing for moderators is important because researchers can identify 
whether certain effects, such as the influence of social norms on doping intentions, need to be 
dealt with differently in various groups (e.g., males versus females) or in certain contexts 
(e.g., competitive athletes versus gym users). Further, moderator analysis could help 
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researchers to explore whether doping interventions are equally effective across populations 
and settings. The third aim of this study was to test a path analysis model, using the meta-
analyzed effect sizes, using variables proposed by TPB [13]. We chose TPB for the path 
analysis because most of the empirical studies in the extant literature were based on this 
theory.  
2 Methods 
2.1 Information Sources and Search Strategy 
A literature search was conducted to identify studies that could be included in the 
meta-analysis. PsycINFO, PsycARTICLES, PubMed, Google Scholar, and Medline were 
searched using combinations of keywords specifying the subject (e.g., doping, doping 
intention, steroid) and the context of interest (e.g., sport) with no date limits. The full 
electronic search strategy is described in Electronic Supplementary Material Appendix S1. In 
addition, the WADA website was searched for reports of previous studies funded by the 
agency, and the reference lists of included articles were scanned for relevant manuscripts that 
were not retrieved from the database searches. To locate and retrieve information from 
unpublished datasets, messages were posted on electronic mailing lists (e.g., SPORTPSY) 
reaching out to social science researchers. Authors with a background in doping research 
were also invited via personal email requests to contact us if they had any unpublished 
information that was relevant to our study.  
 
2.2 Eligibility Criteria and Study Selection 
Studies that measured doping behaviors and/or doping intentions and at least one 
other demographic (e.g., age, sex), psychological (e.g., attitudes, morality), or social-
contextual (e.g., participation in team sport, motivational climate) variable were included. 
Using the above criteria, 104 independent studies were identified. When statistical 
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information required for the meta-analysis was not available in the articles retrieved, we 
contacted the authors in order to request it. Forty one studies were excluded because the 
corresponding authors either did not reply or were unable to provide the required information. 
A flow diagram showing the flow of dataset selection is shown in Figure 1. Consequently, the 
final pool included 63 independent studies [4, 17-19, 21-23, 27-82]. The majority of included 
studies were journal articles (number of studies, k = 46). Other sources included online 
datasets (k = 11), theses/dissertations (k = 3), unpublished manuscripts/datasets (k = 2), and a 
report retrieved from the WADA website (k = 1). Most of the included studies were cross-
sectional (k = 55). Far fewer studies used longitudinal/prospective (k = 4) or experimental 
designs (k = 4). 
 
2.3 Data Collection Process/Summary Measures 
Coding of study information was conducted by one author with a sample of studies 
coded independently and cross-checked by another author. We coded for the type of 
publication (e.g., published journal article, student thesis, manuscript under review), study 
design (e.g., cross-sectional, longitudinal/prospective, experimental), background of 
participants (e.g., competitive athletes, gym users, students), type of sport participants 
engaged in (e.g., team, individual), and age group of participants (e.g., adolescent, adults). 
These variables were subsequently tested as potential moderators of effect sizes. The 
summary measures/effect sizes recorded were odds ratios (for dichotomous variables 
predicting doping behaviors), zero-order Pearson’s correlations (when one or both variables 
were interval or continuous), and Cohen’s d (for intervention versus control group 
comparisons). Cronbach's alphas were also recorded to correct for measurement error in the 
meta-analyzed effect sizes [83]. A summary of the information coded in each included study 
is presented in Electronic Supplementary Material Appendix S2. 
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2.4 Assessment of Quality/Risk of Bias  
To ensure study quality would not lead to biases in results, the quality of included 
studies was assessed [84]. The assessment tool developed by Higgins et al. [84] was adopted 
in this study. However, as this tool was designed for studies using an experimental design 
only, we created other criteria (see Electronic Supplementary Material Appendix S3) for 
cross-sectional (e.g., whether valid measures were used) and longitudinal/prospective studies 
(e.g., whether dropout from the study was random). For each criterion, included studies were 
rated as having ‘low risk’ or ‘high risk’ of bias. A study was deemed to have low risk of bias 
if it was rated as having ‘low risk’ for all assessed criteria. The remaining studies (i.e., those 
with one or more criteria being considered as indicating ‘high risk’) were deemed as having 
potential risk of biases. We tried to eliminate risk of bias across studies by actively seeking 
for unpublished datasets and by calculating the fail-safe numbers N statistic (see section 2.6). 
To determine whether the assessment criteria were appropriate, two of the authors 
independently rated the study quality of three studies (one cross-sectional, one 
longitudinal/prospective, and one experimental). The assessment ratings were compared; out 
of 29 ratings given for the three studies, only one was different, and this disagreement was 
resolved after a discussion. The rationales for giving the ratings for each subcategory were 
also discussed between the two raters to ensure that ratings were given based on similar 
evidence or reasons. The assessments of all other studies included in the meta-analyses were 
then conducted by one of the two authors.  
 
2.5 Synthesis of Results 
The random effect methods proposed by Shadish and Haddock [85] were used to 
meta-analyze odds ratios (OR). The procedures suggested by Hunter and Schmidt [83], which 
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also adopt a random effect model, were used for Pearson’s correlations and Cohen’s d. The 
population effect size (OR, correlation [ρ], or standardized difference [δ], respectively) was 
calculated for each meta-analyzed relation, adjusting for sampling error (by taking into 
account the sample size). When computing effect sizes, attenuation due to measurement error 
was corrected using Cronbach’s alphas. As Cronbach’s alphas were not available for all 
recorded effect sizes, the artifact distribution meta-analytical procedures [83] were employed. 
Further, 95% confidence intervals (95% CI) were generated for all meta-analyzed effect sizes. 
If the 95% CI of an effect size did not encompass the point estimate representing a null effect 
(i.e., 1 for OR, 0 for ρ and δ), the effect was considered to be real. When a real effect was 
found, the magnitude of the meta-analyzed effect sizes was labeled using the criteria 
suggested by previous researchers [86, 87]. Essentially, an OR with a value between 1.68 to 
3.47 was considered small, 3.47 to 6.71 medium, and above 6.71 large (the reciprocals of 
these cut-off values were used when OR < 1). The cut-off values used to label small, medium, 
and large correlations were 0.1, 0.3, and, 0.5, respectively; for standardized mean differences, 
we used values of 0.2, 0.5, and 0.8, respectively. 
2.6 Additional Analyses 
To address the issue of possible publication bias in the literature [88], we calculated 
the ‘fail-safe numbers’ (FSNs) when small to medium, medium, or large effects were found. 
A FSN represents the number of studies with null findings which, if included in the meta-
analysis, would reduce the effect to a small size (i.e., 1.68 for OR, 0.1 for correlation, and 0.2 
for standardized differences). The formula provided by Hunter and Schmidt [83] was used to 
derive the FSNs for the meta-analyzed effect sizes. If the FSN corresponding to an effect size 
is large, it is considered unlikely that the effect found is due to publication bias. 
To test for heterogeneity in the obtained effect sizes, the I2 statistic [89] was used. 
Specifically, the I2 is an estimate of the percentage of differences in combined effects sizes 
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which is due to true heterogeneity (i.e., not due to chance). A smaller I2 suggests that effect 
sizes are more consistent across studies. Effect sizes with I2 values smaller than 25% were 
considered to be homogeneous [89]. When I2 values exceeded 25%, heterogeneity was 
suggested and moderator analyses were conducted. In essence, separate sub-group effect 
sizes were calculated for each level of the potential moderator (e.g., separate effect sizes for 
the moral disengagement-doping intention relationship were calculated for different types of 
study design). A variable was considered to be a moderator if the 95% CIs of any two sub-
group effect sizes did not overlap [90]. The potential moderators we tested in this study were: 
sex of participants (males versus females), publication status (published [k = 46] versus 
unpublished [k = 17]), study design (cross-sectional [k = 55] versus longitudinal/prospective 
[k = 4] versus experimental [k =4]), background of participants (competitive athletes [k = 16] 
versus gym users [k = 12] versus students [k = 35]), type of sport (team sports [k = 4] versus 
individual sports [k = 11] versus a mixture of both [k = 21]), age group of participants (adults 
[k = 22] versus adolescents [k = 29] versus a mixture of both [k = 10]), and study quality 
(studies with low risk of bias [k = 55] versus studies with potential risk of bias [k = 8]). 
Using the meta-analyzed effect sizes we conducted a path analysis of a model based 
on the TPB [13]. Path analysis and meta-analysis can complement each other [91, 92]. Path 
analysis can capture interdependencies between variables that meta-analysis cannot capture, 
because the latter can look at the relation of only two variables at a time. On the other hand, 
meta-analysis removes the effects of artifacts (i.e., sampling error) from data before path 
analysis. Hence, our path analysis takes the two-variable associations of the TPB variables 
established by the meta-analysis and tests them in a multiple variable context. 
3 Results 
The results of all meta-analyzed effect sizes are presented in Table 1. A glossary of 
the specialized terms in this table is provided in Electronic Supplementary Material Appendix 
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S4. Effect sizes from a single study are shown in the tables but will not be interpreted further. 
Where moderator effects were found, the sub-group effect sizes are presented in Table 2.  
 
3.1 Effect Sizes of Experimental Studies Comparing Intervention and Control Groups 
With respect to doping behaviors, we compared the differences in numbers of new 
reported cases of doping between the intervention and control groups over a sport season/ 
school year. We found that the interventions did not show a real effect in terms of reducing 
doping behaviors (OR = 0.76, 95% CI [0.27, 2.17]; OR < 1 indicates there were fewer reports 
of new doping behaviors in intervention groups, but the CI included 1). In terms of doping 
intentions, standardized difference scores between intervention and control groups were 
meta-analyzed. Over the same period of time, the interventions showed a very small 
reduction in doping intentions (δ = ˗0.12, 95% CI [˗0.13, -0.11]). Nonetheless, few studies (k 
= 3 and k = 2 for behaviors and intention, respectively) were included in these analyses 
(hence why forest plots for these studies are not presented), and therefore the results should 
be interpreted with caution.  
3.2 Effect Sizes of Demographic and Social-Contextual Variables Predicting Doping 
Behaviors/Doping Intentions 
Demographic and social-contextual variables were examined in conjunction with 
doping behaviors and/or intentions in the included pool of non-experimental studies. In terms 
of demographic variables, we found that males reported more doping behaviors than females 
(OR = 2.72, 95% CI [2.16, 3.42]). We also found that doping behaviors were more prevalent 
in people who had friends that doped, compared to those who did not (OR = 6.40, 95% CI 
[3.46, 11.84]). The use of legal supplements was related to more doping behaviors (OR = 
8.24, 95% CI [5.07, 13.39]) and higher levels of doping intentions (ρ = 0.36, 95% CI [0.20, 
0.52]). Age was also found to be related to doping intentions (ρ = 0.05, 95% CI [0.02, 0.09]). 
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However, the size of this effect is very small.  
In terms of moderator analyses, we found that the background of participants 
moderated the effect between sex and doping behaviors. Specifically, we found that this 
effect was stronger for gym users (OR = 7.77, 95% CI [5.31, 11.37]) than competitive 
athletes (OR = 2.17, 95% CI [1.16, 4.08]) and students (OR = 2.48, 95% CI [2.04, 3.00]). For 
the relation between age and doping behaviors, a very small negative effect was found in 
female (ρ = ˗0.03, 95% CI [˗0.05, ˗0.02]), but not in male participants (ρ = 0.005, 95% CI 
[˗0.01, 0.02]). Another moderator of the association between age and doping behaviors was 
the background of participants. Specifically, we found a very small effect between these 
variables in gym users (ρ = 0.09, 95% CI [0.01, 0.17]), but not in students (ρ = ˗0.01, 95% CI 
[˗0.02, 0.003]) as the 95% CIs did not overlap. Further, studies with low risks of bias showed 
a very small negative effect of age on doping behaviors (ρ = -0.01, 95% CI [-0.02, -0.001]), 
but those with potential risk of bias reported a small positive effect (ρ = 0.14, 95% CI [0.07, 
0.21]). We also found that study design was a moderator of the age – doping intentions 
relation. Although a very small effect was found in both cross-sectional studies (ρ = 0.07, 
95% CI [0.04, 0.11]) and longitudinal/prospective studies (ρ = 0.003, 95% CI [0.002, 0.004]), 
their corresponding 95% CIs did not overlap, indicating that these effect sizes were not 
equivalent. 
 
3.3 Effect Sizes of Psychological Variables Predicting Doping Behaviors/Doping 
Intentions 
Some of the effect sizes of psychological variables predicting doping behaviors and 
intentions were based on a very small number of studies. Consequently, moderator analyses 
could not be conducted because when these effect sizes were broken down to moderator 
subgroups, there was insufficient number of studies for all subgroups to allow meaningful 
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comparisons. To allow more meaningful comparisons across different levels of moderators, 
two more stages of analyses were conducted, after the initial stage that calculated an effect 
size for each psychological variable. In stage two, we collapsed the effect sizes of variables 
that are conceptually similar (e.g., self-efficacy to refrain from doping and perceived 
behavioral control; see Table 1 for details regarding how variables were combined) with 
appropriate reversing (e.g., moral disengagement was reversed when combining effect sizes 
of morality variables). If conceptually similar constructs were measured in the same study, 
the weighted averages of the coefficients of interest were used to form a single effect size 
from this study for the meta-analysis. For brevity reasons, we report below the findings from 
Stages 2 and 3 only, but the results from all stages are shown in Table 1. 
With respect to doping behaviors, we found positive effects from intentions (ρ = 0.38, 
95% CI [0.21, 0.55]), attitudes (ρ = 0.17, 95% CI [0.04, 0.29]), norms (ρ = 0.36, 95% CI 
[0.27, 0.45]), and amotivation (ρ = 0.17, 95% CI [0.07, 0.26]). The sizes of these effects were 
small to medium. Negative effects on doping behaviors were also found from self-efficacy to 
refrain from doping (ρ = ˗0.12, 95% CI [˗0.21, ˗0.02]), morality (ρ = ˗0.21, 95% CI [˗0.32, 
˗0.10]), autonomous motivation (ρ = ˗0.06, 95% CI [˗0.09, ˗0.03]), and task achievement goal 
orientation (ρ = ˗0.09, 95% CI [˗0.17, ˗0.01]). The effects of the latter two variables though 
were small. The FSN for the effect between self-efficacy to refrain from doping and doping 
behaviors was 1 (k = 5), suggesting that only one study with null findings was need to reduce 
this effect to what is considered a small effect (i.e., reduce it from ρ = ˗0.12 to ρ = ˗0.10).  
In terms of predicting doping intentions, large positive effects were found for attitudes 
(ρ = 0.52, 95% CI [0.44, 0.60]) and norms (ρ = 0.53, 95% CI [0.43, 0.63]). Small effects were 
found for dissatisfaction with appearance/body image (ρ = 0.20, 95% CI [0.12, 0.29]), 
amotivation (ρ = 0.24, 95% CI [0.20, 0.27]), and ego achievement goal orientation (ρ = 0.14, 
95% CI [0.09, 0.20]). However, the effect size between doping intentions and ego 
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achievement goal orientation has a FSN of 2 (k = 4). Small to moderate negative effects were 
also found from self-efficacy to refrain from doping (ρ = ˗0.27, 95% CI [˗0.41, ˗0.14]) and 
morality (ρ = ˗0.31, 95% CI [˗0.47, ˗0.16]). An effect was also found from task achievement 
goal orientation (ρ = ˗0.08, 95% CI [˗0.14, ˗0.02]). Nonetheless, the size of this latter effect is 
small. 
For the third stage of the analyses, variables were categorized as either a positive or 
negative correlates of doping intention or behaviors. A variable was categorized as a positive 
correlate if a real positive effect with doping intention/behaviors was found in the previous 
stages. In contrast, variables with real negative effects were considered as negative correlates. 
Based on this categorization, we collapsed the effect sizes associated with all positive and 
negative correlates and conducted meta-analyses and moderator analyses using the combined 
effect sizes. The variables included in these analyses are shown in Table 1. Forest plots 
representing the third stage of meta-analyses are presented in Electronic Supplementary 
Material Appendix S5.  
We found that the effect sizes associated with the positive (ρ = 0.20, 95% CI [0.08, 
0.32]) and negative (ρ = ˗0.13, 95% CI [˗0.19, ˗0.07]) correlates were small to medium. The 
FSN for the effect between doping behaviors and negative correlates was also small (FSN = 4, 
k = 11), suggesting that a relatively small number of studies (i.e., 4) with null findings would 
bring the meta-analyzed effect to a small value. With respect to doping intentions, we found a 
medium effect from positive (ρ = 0.44, 95% CI [0.36, 0.51]) and negative (ρ = ˗0.28, 95% CI 
[˗0.39, ˗0.17]) correlates. 
In this third stage of the analysis we also found some moderation effects. For the 
positive correlates – doping behaviors relation, a medium effect size was found when only 
studies with low risk of bias were included (ρ = 0.31, 95% CI [0.21, 0.41]). However, a small 
negative effect was found in studies that were rated to have potential risks of bias (ρ = -0.10, 
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95% CI [-0.13, -0.06]). We also found that the relation between positive correlates and 
doping intentions was moderated by publication status and study design. Specifically, we 
found that the effects in published datasets (ρ = 0.49, 95% CI [0.40, 0.59]) were stronger than 
those found in unpublished datasets (ρ = 0.31, 95% CI [0.24, 0.39]). Nonetheless, the size of 
both effects was medium. In terms of study design, we found a medium effect for cross-
sectional studies (ρ = 0.40, 95% CI [0.31, 0.48]), but a large effect for 
longitudinal/perspective studies (ρ = 0.56, 95% CI [0.52, 0.61]). Study design also moderated 
the negative correlates-doping intentions relation. A small effect was found in cross-sectional 
studies (ρ = ˗0.21, 95% CI [˗0.33, ˗0.10]), but the magnitude of the effect was stronger in 
longitudinal/prospective studies (ρ = ˗0.44, 95% CI [˗0.45, ˗0.43]). Finally, we found that the 
effect size between negative correlates and doping intentions was small in competitive 
athletes (ρ = ˗0.16, 95% CI [˗0.29, ˗0.02]), but large in gym users (ρ = ˗0.62, 95% CI [˗0.85, 
˗0.40]). 
 
3.4 Path Analyses of a Theory of Planned Behavior Model 
The TPB [13, 20] was the most frequently utilized theoretical framework within the 
pool of included studies. Thus, in order to examine the inter-relation between all TPB 
constructs and doping behaviors and intentions, we conducted path analyses using meta-
analyzed effect sizes from the second stage of our analyses. Path analyses were conducted 
using the Mplus 6.1 software [93]. Following recommendations by Viswesvaran and Ones 
[92], the harmonic mean of the sample sizes underpinning the corresponding effect sizes of 
the correlation matrix was used as the total sample size (n = 5,046) for the tested models. 
Based on the model proposed by Ajzen [13], we tested an initial model with attitudes, norms, 
and self-efficacy to refrain from doping predicting intentions to dope; the latter, in turn, 
predicted doping behaviors. We used self-efficacy to refrain from doping instead of perceived 
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behavioral control as they both reflect efficacy beliefs. Further, past evidence has shown that 
self-efficacy to refrain from doping is a stronger predictor of doping intentions [16] and, in 
contrast to perceived behavioral control, a significant predictor of doping intentions in both 
users and non-users [94]. This model did not fit well [95]: 2 (3) = 288.98, p < 0.001, 
comparative fit index (CFI) = 0.92, root mean square error of estimation (RMSEA) = 0.14, 
standardized root mean square residual (SRMR) = 0.04. 
We tested three other plausible alternative models by freeing direct paths from 
attitudes, norms, and self-efficacy to refrain from doping (only one of these paths was freed 
in each alternative model) to doping behaviors. A plausible model was accepted if the 
improvement in CFI was larger than 0.01 compared to the initial model [96]. The alternative 
models with direct paths from attitudes or self-efficacy to refrain from doping to behaviors 
did not meet this criterion and were rejected. However, the model with a direct path from 
norms to doping behaviors (see Figure 2) was accepted (change in CFI = 0.060). This final 
model had a significant 2, but other fit indices suggested an acceptable model fit: 2 (2) = 
78.35, p < 0.001, CFI = 0.98, RMSEA = 0.09, SRMR = 0.02. In this model, the direction of 
paths from attitudes (β = 0.31), norms (β = 0.34), and self-efficacy to refrain from doping (β 
= ˗0.14) to doping intentions were in the expected direction (all path p < 0.001). Paths from 
norms (β = 0.22, p < 0.001) and intention (β = 0.26, p < 0.001) to doping behaviors were also 
positive. Indirect effects on doping behaviors from attitudes (β = 0.12) and self-efficacy to 
refrain from doping (β = ˗0.06) were also significant at p < 0.001. 
 
4 Discussion 
This article represents the first meta-analysis within the doping literature. Its primary 
aim was to synthesize data from independent samples in an effort to identify key 
demographic, psychological, and socio-contextual factors that are related to doping intentions 
Running head: PERSONAL AND PSYCHOSOCIAL PREDICTORS OF DOPING 19 
and doping behaviors. In sum, our findings corroborate Petróczi and Aidman’s [97] argument 
that decisions to dope reflect a complex interplay of multiple factors and may not be 
accurately explained by a few variables alone. This is a notable conclusion when one 
considers that although a variety of social cognitive models purporting to delineate the key 
determinants of behavior exist, the TPB has been the most widely tested theory in the context 
of doping in sport. Moreover, for some of the identified predictor variables there was only a 
limited pool of studies available. Consequently, the findings with regard to these variables 
must be interpreted with caution, including findings from experimental studies. Nevertheless, 
collapsing the variables in the final stage analysis of positive and negative correlates of 
doping intention and behaviors gives some indication of the magnitude of the statistical 
effects, which were small to medium. This meta-analysis reconfirms the conclusion drawn by 
Backhouse and colleagues [25] that the evidence base on the psycho-social predictors of 
doping intentions and behaviors is limited by span and methodology. This absence of 
evidence continues to be an important consideration for policy makers and developers of anti-
doping prevention programs. 
 
4.1 Effect of interventions on doping intentions and behavior 
We firstly evaluated the effectiveness of existing randomized controlled trials (RCTs) 
and only four experimental studies met the eligibility criteria for inclusion in our meta-
analysis. The four studies presented data from the evaluations of two long-standing North 
American prevention programs, namely the ATLAS [42, 98, 99], and ATHENA [26, 99] 
programs. The ATLAS/ATHENA-based RCTs included in our analyses showed a very small 
but significant reduction in doping intentions but no changes in doping behavior. This might 
be attributed to the content of the ATLAS and ATHENA interventions. Both tackle doping 
alongside other behaviors, such as healthy eating and training regimes. Perhaps the lack of a 
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clear focus on doping explains the small effect on intentions and the non-significant effect on 
actual behavior. In particular, ATHENA is largely focused on information and activities 
about healthy and disordered eating, drug use (i.e., alcohol, tobacco, marijuana, and anabolic 
steroids), monitoring nutritional intake, and improving psychological factors, such as 
depression and mood [26, 67, 100]. Hence, both interventions aim to influence adolescent 
athletes’/students’ overall health-related behaviors, and this may happen at the expense of a 
greater focus on doping use. Furthermore, it is possible that the small effects found in the 
ATLAS/ATHENA interventions reflect floor effects: participants’ doping intentions at 
baseline (pre-intervention) were low. Therefore, there was not much room for a further 
reduction in intentions and behavior. For example, in Goldberg et al.’s [98] study, pre-
intervention intentions to use steroids were 5.7 and 6.3 in the experimental and control groups 
respectively (1-7 scale with 7 being no intent to use).  
4.2 Effect sizes of demographic and social-contextual variables 
Effect sizes from non-experimental studies were also included in the present meta-
analysis. We looked at the effect sizes associated with demographic and socio-contextual 
variables. Males and gym users were more likely to report doping use compared to females 
and competitive athletes or students. Further, the use of legal nutritional supplements and 
being affiliated with peers who use doping substances, predicted greater self-reported doping 
use. Use of legal supplements had a large positive effect on doping behavior. This suggests 
that users of legal supplements are at a much higher risk of using illegal drugs. This finding is 
notable when one considers the widespread use of legal supplements across all levels of sport 
[101-104]. In a recent study, Backhouse et al. [23] suggested that a gradual increase in 
nutritional supplements’ consumption served as a gateway to doping use. Specifically, in a 
sample of competitive athletes, Backhouse and colleagues found that doping use was three-
and-a-half times more prevalent in nutritional supplement users as compared to nonusers. 
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This finding was accompanied by significant differences in doping attitudes and beliefs 
between nutritional supplement users and nonusers. A potential explanation is that the 
habitual use of otherwise legal nutritional supplements familiarizes athletes with the notion of 
chemically-assisted performance enhancement [97] and this can further facilitate transitions 
to doping use. In a similar vein, Tsorbatzoudis et al. [105] indicated that nutritional 
supplement users are two to three times more likely to report doping use and they also 
displayed biased normative beliefs related to doping use (i.e., they perceived doping as more 
prevalent in fellow athletes and socially approved).  
 
4.3 Effects of psychological variables  
The present meta-analysis also investigated the effects of psychological variables on 
doping intentions and behavior. Specifically, task goal orientation was inversely related to 
doping use, whereas ego goal orientation and controlled motivation were positively related. 
These findings suggest that ego-oriented and externally regulated athletes display a more 
maladaptive set of behavioral responses. These athletes are more inclined to dope and this 
should be taken into account when developing prevention education interventions. 
Many of the included studies utilized TPB but expanded on this framework by 
utilizing their own measures and incorporating additional distal predictors of doping behavior. 
The meta-analysis showed that pro-doping attitudes and biased normative beliefs (i.e., 
overestimating the actual prevalence and social acceptability of doping use) directly and 
positively predicted doping intentions. Accordingly, higher scores in self-efficacy to resist 
temptations and anticipated regret inversely predicted doping intentions and use. These 
findings imply that the TPB - and its extensions - offer a useful framework for understanding 
the decision making process towards doping use.  
Having said this, it is important to acknowledge that the TPB is a highly rational 
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model and Ajzen [106] argues that it does not adequately account for the cognitive and 
affective processes which bias judgments and behavior. Stewart and Smith [107] have argued 
that athletes’ decisions may not always rest on rational thinking. This may also apply to 
intentions to dope which might be based on unconscious factors which bias judgment. Further, 
doping use might be un-intentional via the consumption of contaminated nutritional 
supplements [108]. Therefore, the application of alternative models and methods is 
encouraged in this field in order to further our understanding of the complex doping 
phenomenon. Further, new approaches have been proposed suggesting that doping use is 
influenced by the interplay of sociocultural, socioeconomic, and personality factors. For 
instance, Donovan et al. [109],  Petroczi and Aidman [97], and Strelan and Boeckmann [110] 
discussed the role of personality factors, decisions regarding the pros and cons of doping use, 
the legislative system, the affordability, and availability of prohibited substances. Stewart and 
Smith [107] provided a macro-analysis of doping use in sport suggesting that, alongside to 
personality factors, globalization and commercialization of sport, and sport cultures are key 
factors in explaining doping use. However, research testing these ideas is rather scarce and 
future studies which take into account these variables are encouraged [107].  
In the current study higher levels of sportspersonship and moral disengagement 
negatively predicted doping intentions and doping use. These findings highlight the important 
role of morality in preventing doping use. Finally, dimensions of body image, more 
specifically, concerns about muscularity and thinness, and overall dissatisfaction with body 
appearance were found to significantly relate to doping intentions and doping use. These 
findings suggest that maladaptive perceptions of body image may facilitate doping use. This 
could be through the use of illegal substances as these can be used as a strategy to augment or 
reduce an individual’s physique. Therefore, body image should be targeted in prevention 
programs, particularly those that reach adolescent athletes. 
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In this meta-analysis we also examined whether several factors moderated the 
reported effect sizes. Although some of the effects varied in size across different levels of 
moderators, in general, the direction of the effects remained unchanged. However, we found 
that the effect sizes from some studies deemed as having potential biases may alter the 
directions of the effect in an unexpected way (e.g., a negative effect between positive 
correlates of doping and doping behaviors). Further, published studies reported bigger effect 
sizes than unpublished ones. These findings, therefore, emphasize the importance of 
eliminating possible sources of biases when conducting empirical research in this field to 
avoid dubious results.  
 
4.4 Path Analysis 
Using the meta-analyzed effect sizes, we also tested a path model based on the TPB. 
We found that the paths from attitudes, perceived norms, and self-efficacy to refrain from 
doping, were significant predictors of doping intentions, and in the expected direction. 
Furthermore, a positive path from doping intentions to doping behaviors was found. By 
comparing alternative nested models, we also found that perceived norms had a direct effect 
on doping behaviors. These results are slightly unexpected because in the TPB literature 
perceived norms are often found to be the weakest, or even non-significant, predictor of 
intentions [111, 112]. However, unlike many non-doping related TPB studies that assessed 
social norms through subjective norms (i.e., perceived social approval of doping), many of 
the studies we analyzed assessed other aspects of social norms, such as descriptive norms (i.e., 
what significant others themselves do). This encompassing assessment appears important 
when one considers the assertion that the role of norms varies dependent on the type of 
behavior [113].  
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Overall, the findings of this meta-analysis underscore the importance of normative 
influences on doping use. Normative influences to engage in doping can range from mere 
peer pressure and perceived social acceptability of doping by teammates, to internal and 
external pressures associated with results and enhanced performance. Hence, the athlete’s 
entourage (e.g., coach and teammates) and perceptions about the prevalence of doping use 
among other athletes seem to be important determinants of the decision to engage in doping. 
It is noteworthy that perceptions of social norms do not have to be accurate to be influential 
[114] and future research should address the cognitive processes (e.g., heuristics) that lead to 
biased normative beliefs. In order to increase the predictive power of the normative 
component of the TPB, future research could pay closer attention to other normative variables 
(e.g., personal, injunctive and moral norms) [112]. For example, it is unclear whether 
observing the doping behavior of others is of greater motivational importance compared to 
perceived social pressure from others. Finally, Rivis and Sheeran’s [111] observation that 
young people are particularly susceptible to descriptive norms suggests that interventions 
with adolescent groups should be bespoke to the needs of that group in order to foster a 
strong sense of individuality and uniqueness. 
4.5 Limitations 
The most important limitation of this work is that many meta-analyzed effect sizes 
were based on a small number of studies. This is because the studies conducted in this area 
have been very broad, perhaps too broad, in terms of identifying demographic, personal, and 
situational predictors of doping intentions and behavior. Nevertheless, this review represents 
an initial effort to quantify the psychosocial variables that are most strongly related to doping 
behaviors or intentions to engage in such behaviors. Also, the current conclusions assume 
that self-reported behaviors are accurate reflections of people’s actions (all included studies 
used self-reports to measure doping behavior/use). Further, most of the meta-analyzed effect 
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sizes between predictors of doping with doping intentions and behaviors were derived from 
correlational studies; more prospective and intervention studies are needed in this area.  
As a consequence, the identified effect sizes show statistical and not causal effects. 
For example, a large effect size between perceived norms and intentions may also suggest 
people having stronger intentions to dope would perceive more people to be doping [63]. 
Similarly, people may report having more positive attitudes towards doping because they 
intend to use illegal substances. Another limitation was that we were unable to test some 
potentially important moderator effects. For example, in studies that reported the numbers or 
percentages of participants using legal substances, these were reported for the total sample 
and not by subgroups. Therefore, comparing effect sizes for different levels of moderators 
was not possible, unless authors were willing to provide us with access to their raw data.  
4.6 Practical Implications  
Anti-doping education should target normative influences and attempt to de-
normalize doping use in sports and exercise settings. Prevention programs are particularly 
encouraged in the early adolescent years when attitudes are forming [115] and when 
adolescents tend to be more vulnerable to normative influences. Thus, related interventions 
should be more intensive for this age group and greater attention should be afforded to peer 
influence and related socio-emotional processes that facilitate risky behavior under social 
pressure [116, 117]. For example, forging a unique and individual identity could be important 
in this context as adolescents appear particularly susceptible to descriptive norms [111]. 
Finally, there are experimental studies that have demonstrated powerful effects of norms-
based interventions in changing adults’ behavior [118, 119]. Doping researchers could utilize 
these findings and develop norms-based interventions to reduce the risk for doping use.  
Future research and preventive guidelines regarding the social environment should 
also focus on the role of coaches and athlete support personnel in promoting adaptive types of 
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motivation (autonomous motivation, task achievement goals). Importantly, future prevention 
interventions should improve athletes’ self-efficacy in resisting temptations (i.e., outcomes of 
success such as money, fame etc.) which might lead to doping use. In addition, aspects of 
ethical decision making should be incorporated in interventions designed to tackle doping use. 
Finally, doping-related interventions should inform athletes on the risks and appropriate use 
of nutritional supplements. In recent years, contaminated nutritional supplements have 
become a real cause for concern [108] and at a global level there has been a growing number 
of claims of inadvertent doping through the use of nutritional supplements. So that athletes 
can make an informed choice, there is an urgent need to regulate the industry and undertake 
efficacy trials to assess the performance benefits and health risks associated with the use of 
these supplements. Furthermore, the use of nutritional supplements may act as a gateway to 
illegal drug use [23] and this should be acknowledged through increased educational efforts 
in this area.  
5 Conclusions 
 In sum, we found that doping behaviors may be explained by a combination of 
demographic, social-contextual, and psychological variables. However, the available 
evidence is still not sufficient in volume and rigorous enough in terms of methodology or 
diverse enough in terms of its conceptual underpinnings, and this limits our understanding of 
doping intentions and doping use in sport. Nevertheless, our results support a curriculum shift 
by placing greater emphasis on modifying norm-based doping perceptions and creating coach 
and peer task-involving motivational climates. Effective prevention interventions to tackle 
doping use should target athletes’ motivation, cognitions and moral stance, empowering 
athletes and their entourage to resist unethical temptations and pursue performance 
improvements through the use of legal substances and methods.  
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Table 1 
Results of meta-analyses and homogeneity tests predicting doping behavior and doping intentions 
 k n Effect size 95% CI FSN I2 (%) 
Stage one analyses       
Comparisons of intervention and control groups 
(Scores of intervention groups minus those of 
control groups) 
      
Behavior (pre- to post-season/school year) 3 3,718 0.76a 0.27, 2.17 — 40.8 
Behavior (1 year post-intervention) 1 1,291 0.36a 0.12, 1.10 — — 
Intention (pre- to post-season/school year) 2 3,333 -0.12b -0.13, -0.11 — 0.0 
Intention (1 year post-intervention) 1 1,291 -0.13b -0.24, -0.02 — — 
       
Predicting doping behaviors       
Demographic variables       
Sex (males vs. females) 43 247,590 2.72a 2.16, 3.42 40 84.2 
Age 34 182,435 -0.01c -0.02, 0.003 — 82.2 
Legal supplement use 6 4,568 8.24a 5.07, 13.39 19 60.2 
Know friend who has doped 5 2,224 6.40a 3.46, 11.84 13 0.0 
       
Social-contextual environment       
Team sports participation (versus other types) 5 3,309 0.96a 0.67, 1.38 — 0.0 
Task-involving motivational climate 1 374 0.07c -0.03, 0.17 — — 
Ego-involving motivational climate 1 374 -0.08c -0.18, 0.02 — — 
       
Theory of Planned Behavior variables       
Intentiond 10 5,544 0.38c 0.21, 0.55 29 98.9 
Attitudes 13 7,992 0.12c -0.06, 0.30 — 98.7 
Knowledge of doping 1 2,285 0.08c 0.04, 0.12 — — 
Perceived benefits of doping 3 1,551 0.27c 0.16, 0.37 5 82.2 
Perceived negative outcomes of doping 1 167 -0.08c -0.23, 0.07 — — 
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Beliefs regarding whether doping should be legalized 1 205 0.52c 0.42, 0.62 5 — 
Subjective norms 8 4,084 0.36c 0.23, 0.48 21 95.6 
Descriptive norms 3 1,233 0.49c 0.27, 0.70 12 95.4 
Moral norms 1 640 0.40c 0.33, 0.46 3 — 
Perceived behavioral control 5 3,073 -0.01c -0.07, 0.05 — 59.4 
Self-efficacy to refrain from doping 1 762 -0.22c -0.29, -0.16 2 — 
Situational temptations 2 949 0.47c 0.42, 0.52 8 34.7 
       
Other personal psychological variables       
Sportspersonship 4 3,159 -0.15c -0.21, -0.09 2 72.2 
Moral disengagement 3 2,358 0.30c 0.10, 0.49 6 97.0 
Dissatisfaction with appearance or body imaged 1 203 0.15c 0.02, 0.29 1 — 
Autonomous motivatione 6 3,779 -0.06c -0.09, -0.03 — 0.0 
Controlled motivation 6 3,777 0.02c -0.02, 0.06 — 28.1 
Amotivationd 5 2,574 0.17c 0.07, 0.26 4 83.6 
Task goal orientatione 5 2,543 -0.09c -0.17, -0.01 — 77.2 
Ego goal orientation 5 2,536 0.04c -0.02, 0.11 — 62.7 
Global self-esteem 3 924 -0.03c -0.07, 0.01 — 0.0 
Perfectionism 2 463 -0.10c -0.19, 0.001 — 50.1 
Religiousnesse 1 27 -0.58c -0.84, -0.32 5 — 
Sport confidence 1 374 -0.04c -0.15, 0.06 — — 
Anticipated regrete 1 641 -0.13c -0.21, -0.05 1 — 
Threat of being caught 1 644 0.04c -0.04, 0.12 — — 
Willingness to doped 1 726 0.54c 0.49, 0.59 5 — 
       
Predicting doping intentions       
Demographic variables       
Sex (males versus females) 10 6,029 0.07c -0.004, 0.15 — 90.6 
Age 11 6,350 0.05c 0.02, 0.09 — 39.0 
Legal supplement use 3 2,110 0.36c 0.20, 0.52 8 95.8 
Social-contextual environment       
Team sports participation (versus other types) 1 218 0.08c -0.05, 0.21 — — 
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Theory of Planned Behavior variables       
Attitudes 14 6,878 0.55c 0.47, 0.63 63 93.1 
Knowledge of doping 1 144 0.28c 0.13, 0.43 2 — 
Perceived benefits of doping 2 909 0.17c -0.01, 0.35 — 93.8 
Perceived negative outcomes of doping 2 421 -0.25c -0.33, -0.16 3 9.3 
Beliefs regarding whether doping should be legalized 1 203 0.75c 0.69, 0.81 7 — 
Subjective norms 11 5,409 0.55c 0.44, 0.65 49 93.2 
Descriptive norms 3 1,166 0.21c 0.10, 0.32 4 77.7 
Moral norms 1 646 0.65c 0.60, 0.69 6 — 
Social support to use illegal substances 1 144 0.33c 0.18, 0.48 3 — 
Perceived behavioral control 8 4,456 -0.08c -0.27, 0.10 — 98.4 
Self-efficacy to refrain from doping 4 2,102 -0.55c -0.60, -0.49 18 53.9 
Situational temptations 2 955 0.68c 0.43, 0.92 12 97.8 
       
Personal psychological variables       
Sportspersonship 3 1,963 -0.10c -0.22, 0.02 1 89.7 
Moral disengagement 3 2,657 0.48c 0.40, 0.57 12 84.1 
Dissatisfaction with appearance or body image 3 529 0.19c 0.03, 0.36 3 77.8 
Drive for thinness 1 864 0.16c 0.10, 0.23 1 — 
Drive for muscularity 1 864 0.21c 0.15, 0.28 2 — 
Autonomous motivation 5 2,585 -0.11c -0.23, 0.002 1 90.2 
Controlled motivation 5 2,583 0.02c -0.04, 0.07 — 43.7 
Amotivationd 5 2,581 0.24c 0.20, 0.27 7 0.0 
Task goal orientatione 4 2,179 -0.08c -0.14, -0.02 — 44.3 
Ego goal orientationd 4 2,172 0.14c 0.09, 0.20 2 38.6 
Global self-esteem 1 191 -0.03c -0.18, 0.11 — — 
Anticipated regrete 1 644 -0.53 -0.59, -0.48 5 — 
Willingness to doped 1 726 0.16 0.06, 0.24 1 — 
       
Stage two analyses       
Predicting doping behaviors       
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Theory of Planned Behavior variables       
Attitudesd 
(including: knowledge of doping, perceived 
benefits of doping, perceived negative outcomes of 
doping [reversed], beliefs regarding whether doping 
should be legalized) 
16 8,227 0.17c 0.04, 0.29 11 96.8 
Normsd 
(including: subjective norms, descriptive norms, 
moral norms) 
9 4,160 0.36c 0.27, 0.45 24 90.3 
Self-efficacy to refrain from dopinge 
(including: perceived behavioral control, situational 
temptations [reversed]) 
5 3,073 -0.12c -0.21, -0.02 1 87.5 
       
Other personal psychological variables       
Moralitye 
(including: sportspersonship, moral disengagement 
[reversed]) 
7 5,517 -0.21c -0.32, -0.10 8 94.9 
       
Predicting doping intentions       
Theory of Planned Behavior variables       
Attitudesd 
(including: knowledge of doping, perceived 
benefits of doping, perceived negative outcomes of 
doping [reversed], beliefs regarding whether doping 
should be legalized) 
14 6,829 0.52c 0.44, 0.60 60 92.0 
Normsd 
(including: subjective norms, descriptive norms, 
moral norms, social support to use illegal 
substances) 
11 5,402 0.53c 0.43, 0.63 48 92.6 
Self-efficacy to refrain from dopinge 
(including: perceived behavioral control, situational 
temptations [reversed]) 
9 4,601 -0.27c -0.41, -0.14 16 95.6 
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Personal psychological variables       
Moralitye 
(including: sportspersonship, moral disengagement 
[reversed]) 
6 4,620 -0.31c -0.47, -0.16 13 96.8 
Dissatisfaction with appearance or body imaged 
(including: drive for thinness, drive for muscularity)
4 1,393 0.20c 0.12, 0.29 5 66.6 
       
Stage three analyses       
Predicting doping behaviors       
Positive correlates  17 9,297 0.20c 0.08, 0.32 17 97.2 
Negative correlates 11 6,538 -0.13c -0.19, -0.07 4 82.1 
       
Predicting doping intentions       
Positive correlates 15 7,875 0.44c 0.36, 0.51 51 92.5 
Negative correlates 11 5,819 -0.28c -0.39, -0.17 20 94.8 
       
Note. k = number of meta-analyzed studies; n = total number of participants; CI = confidence interval; FSN = fail-safe number, i.e., number of 
studies with null findings which, if included in the meta-analysis, would reduce the estimated effect to a small size (if it is not already small); — 
= not applicable; I2 = test of homogeneity (shown when k>1). aOdds ratios; bCohen’s d; cCorrelation coefficient. dVariable considered as a 
positive correlate in stage three analyses; eVariable considered as an negative correlate in stage three analyses.
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Table 2 
Differences in effect size across levels of moderators 
Relationship [levels of moderator(s)] k n Effect size 95 % CI I2 (%) 
Stage one analyses      
Sex – Doping behaviorsa 
Participant background 
     
Competitive athletes 12 4,834 2.17 1.16, 4.08 56.1 
Gym users 4 2,692 7.77 5.31, 11.37 36.5 
Students 27 240,064 2.48 2.04, 3.00 86.1 
Age – Doping behaviorsb      
Sex of participants      
Males 33 89,680 0.005 -0.01, 0.02 72.3 
Females 28 91,488 -0.03 -0.05, -0.02 73.1 
Study design      
Cross-sectional studies 33 181,673 -0.01 -0.02, 0.001 77.8 
Longitudinal studies 1 762 0.22 0.15, 0.28 — 
Participant background      
Gym users 5 713 0.09 0.01, 0.17 39.0 
Students 18 176,377 -0.01 -0.02, 0.003 88.5 
Participant age group      
Adolescents 15 168,668 -0.01 -0.02, -0.001 81.8 
Mixed adults and adolescents 7 6,867 0.07 0.02, 0.13 85.1 
Risk of bias      
Studies with low risk of bias 31 179,895 -0.01 -0.02, -0.001 74.8 
Studies with potential risk of bias 3 2,540 0.14 0.07, 0.21 78.5 
Intention – Doping behaviorsb      
Sport type      
Team sports participants 1 236 -0.07 -0.20, 0.06 — 
Mixed team and individual sports participants 7 3,946 0.44 0.25, 0.63 98.8 
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Risk of bias      
Studies with low risk of bias 9 5,308 0.40 0.22, 0.57 98.9 
Studies with potential risk of bias 1 236 -0.06 -0.19, 0.07 — 
Attitudes – Doping behaviorsb      
Risk of bias           
Studies with low risk of bias 11 5,477 0.29 0.16, 0.42 96.5 
Studies with potential risk of bias 2 2,515 -0.36 -0.48, -0.23 89.7 
Perceived positive effects – Doping behaviorsb      
Participant age group      
Adults 2 909 0.34 0.16, 0.37 0.0 
Mixed adults and adolescents 1 642 0.16 0.09, 0.24 — 
Subjective norms – Doping behaviorsb      
Sport type      
Team sports participants 1 236 -0.06 -0.19, 0.06 — 
Mixed team and individual sports participants 6 2,896 0.39 0.25, 0.54 95.5 
Risk of bias           
Studies with low risk of bias 7 3,848 0.38 0.26, 0.50 94.9 
Studies with potential risk of bias 1 236 -0.06 -0.19, 0.06 — 
Descriptive norms – Doping behaviorsb      
Sex of participants      
Males 2 599 0.64 0.61, 0.67 0.0 
Females 3 464 0.26 0.15, 0.37 61.3 
Participant age group      
Adults 2 938 0.59 0.59, 0.60 0.0 
Adolescents 1 295 0.15 0.04, 0.26 — 
Perceived behavioral control – Doping behaviorsb      
Study design      
Cross-sectional studies 4 2,311 -0.05 -0.08, -0.01 0.0 
Longitudinal studies 1 762 0.09 0.02, 0.16 — 
Moral disengagement – Doping behaviorsb      
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Participant background      
Competitive athletes 1 644 0.01 -0.06, 0.09 — 
Students 2 1,714 0.40 0.38, 0.42 0.0 
Amotivation – Doping behaviorsb      
Participant age group      
Adults  1 410 -0.07 -0.16, 0.03 — 
Adolescents  1 304 0.20 0.10, 0.31 — 
Mixed adults and adolescents 3 1,860 0.22 0.17, 0.26 26.8 
Task achievement goal orientation – Doping behaviorsb      
Participant background      
Competitive athletes 4 2,343 -0.07 -0.13, -0.004 60.3 
Students 1 200 -0.32 -0.44, -0.19 — 
Age – Doping intentionsb      
Study design      
Cross-sectional studies 9 4,645 0.07 0.04, 0.11 28.0 
Longitudinal studies 2 1,705 0.003 0.002, 0.004 0.0 
Attitudes – Doping intentionsb      
Sport type      
Team sports participants 1 240 0.73 0.67, 0.79 — 
Mixed team and individual sports participants 8 4,015 0.54 0.41, 0.66 94.1 
Participant age group      
Adults 4 1,567 0.38 0.19, 0.56 95.8 
Mixed adults and adolescents 5 2,195 0.68 0.63, 0.73 70.5 
Perceived benefits – Doping intentionsb      
Publication status / Study design      
Published datasets / Longitudinal studies 1 183 0.43 0.31, 0.55 — 
Unpublished datasets / Cross-sectional studies 1 726 0.10 0.03, 0.17 — 
Descriptive norms – Doping intentionsb      
Participant age group      
Adolescents 1 296 0.07 -0.04, 0.19 — 
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Mixed adults and adolescents 1 144 0.40 0.26, 0.53 — 
Perceived behavioral control – Doping intentionsb      
Participant background      
Competitive athletes 3 1,136 0.11 -0.12, 0.35 93.1 
Gym users 1 253 -0.91 -0.93, -0.89 — 
Students 4 3,067 -0.09 -0.22, 0.04 90.5 
Sport type      
Individual sports participants 1 253 -0.91 -0.93, -0.89 — 
Mixed team and individual sports participants 5 2,841 -0.03 -0.19, 0.12 92.6 
Risk of bias           
Studies with low risk of bias 7 4,274 -0.10 -0.29, 0.09 98.6 
Studies with potential risk of bias 1 182 0.35 0.22, 0.47 — 
Situational temptations – Doping intentionsb      
Participant age group      
Adolescents 1 309 0.42 0.33, 0.51 — 
Mixed adults and adolescents 1 646 0.80 0.77, 0.83 — 
Sportspersonship – Doping intentionsb      
Publication status      
Published datasets 1 1,024 -0.02 -0.08, 0.05 — 
Unpublished datasets 2 939 -0.20 -0.31, -0.09 78.8 
Moral disengagement – Doping intentionsb      
Study design / Participant age group      
Cross-sectional studies / Mixed adults and 
adolescents 
1 952 0.37 0.31, 0.42 — 
Longitudinal studies / Adolescents 2 1,705 0.55 0.54, 0.56 0.0 
Dissatisfaction with appearance – Doping intentionsb      
Participant background      
Competitive athletes 1 182 0.39 0.26, 0.51 — 
Students 1 203 0.06 -0.08, 0.20 — 
Participant age group      
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Adults 1 182 0.39 0.26, 0.51 — 
Mixed adults and adolescents 2 347 0.09 0.04, 0.15 0.0 
Legal supplement use – Doping intentionsb      
Participant age group      
Adolescents 2 1,158 0.23 0.19, 0.27 0.0 
Mixed adults and adolescents 1 952 0.51 0.47, 0.56 — 
Autonomous motivation – Doping intentionsb      
Participant age group      
Adults 1 410 -0.41 -0.49, -0.33 — 
Adolescents 1 307 -0.04 -0.15, 0.07 — 
Mixed adults and adolescents 3 1,868 -0.06 -0.11, -0.02 2.3 
Controlled motivation – Doping intentionsb      
Participant background      
Competitive athletes 3 1,976 -0.01 -0.06, 0.05 37.6 
Students 2 607 0.10 0.09, 0.11 0.0 
      
Stage two analyses      
Attitudes (composite) – Doping behaviorsb      
Risk of bias           
Studies with low risk of bias 14 5,710 0.28 0.18, 0.39 94.2 
Studies with potential risk of bias 2 2,518 -0.10 -0.12, -0.08 0.0 
Norms (composite) – Doping behaviorsb      
Publication status      
Published datasets 6 2,493 0.29 0.17, 0.40 89.8 
Unpublished datasets 3 1,667 0.47 0.42, 0.52 48.5 
Sport type      
Team sports participants 1 236 0.06 -0.07, 0.19 — 
Mixed team and individual sports participants 6 2,890 0.39 0.27, 0.51 91.5 
Participant age group      
Adults  4 1,269 0.50 0.43, 0.56 50.9 
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Adolescents  3 1,299 0.20 0.06, 0.35 90.3 
Risk of bias           
Studies with low risk of bias 8 3,924 0.38 0.29, 0.47 65.1 
Studies with potential risk of bias 1 236 0.06 -0.07, 0.19 — 
Self-efficacy to refrain from doping (composite) – 
Doping behaviorsb 
     
Participant background      
Competitive athletes 2 949 -0.28 -0.32, -0.24 0.0 
Students 3 2,124 -0.04 -0.09, -0.002 8.6 
Morality (composite) – Doping behaviorsb      
Study design      
Cross-sectional studies 6 4,755 -0.18 -0.29, -0.07 94.5 
Longitudinal studies 1 762 -0.39 -0.45, -0.33 — 
Participant background      
Competitive athletes 5 3,803 -0.12 -0.19, -0.06 79.2 
Students 2 1,714 -0.40 -0.42, -0.38 0.0 
Attitudes (composite) – Doping intentionsb      
Sport type      
Team sports participants 1 240 0.72 0.66, 0.78 — 
Individual sports participants 2 397 0.55 0.47, 0.63 28.1 
Mixed team and individual sports participants 8 3,966 0.51 0.38, 0.64 94.4 
Participant age group      
Adults 4 1,518 0.31 0.16, 0.45 89.0 
Adolescents 5 3,116 0.54 0.46, 0.63 88.0 
Mixed adults and adolescents 5 2,195 0.64 0.59, 0.69 49.5 
Norms (composite) – Doping intentionsb      
Sport type      
Team sports participants 1 241 0.70 0.64, 0.76 — 
Mixed team and individual sports participants 7 3,812 0.49 0.36, 0.62 94.3 
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Self-efficacy to refrain from doping (composite) – 
Doping intentionsb 
     
Participant background      
Competitive athletes 3 1,137 -0.32 -0.36, -0.29 0.0 
Gym users 2 397 -0.64 -0.88, -0.41 91.7 
Students 4 3,067 -0.21 -0.40, -0.02 96.0 
Sport type      
Individual sports participants 2 397 -0.64 -0.88, -0.41 91.7 
Mixed team and individual sports participants 5 2,842 -0.34 -0.36, -0.31 0.0 
Morality (composite) – Doping intentionsb      
Study design      
Cross-sectional studies 4 2,915 -0.19 -0.33, -0.04 94.5 
Longitudinal studies 2 1,705 -0.55 -0.56, -0.54 0.0 
Participant background      
Competitive athletes 3 1,963 -0.10 -0.22, 0.02 89.7 
Students 3 2,657 -0.48 -0.57, -0.40 84.1 
      
Stage three analyses      
Positive correlates – Doping behaviorsb      
Risk of bias           
Studies with low risk of bias 15 6,779 0.31 0.21, 0.41 94.8 
Studies with potential risk of bias 2 2,518 -0.10 -0.13, -0.06 16.3 
Negative correlates – Doping behaviorsb      
Study design      
Cross-sectional studies 10 5,776 -0.11 -0.17, -0.06 81.0 
Longitudinal studies 1 762 -0.24 -0.31, -0.17 — 
Participant background      
Competitive athletes 6 4,186 -0.09 -0.14, -0.04 57.5 
Gym users 1 27 -0.65 -0.87, -0.43 — 
Students 4 2,325 -0.19 -0.29, -0.10 83.4 
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Sport type      
Individual sports participants 1 27 -0.65 -0.87, -0.43 — 
Mixed team and individual sports participants 8 5,149 -0.12 -0.17, -0.06 72.7 
Risk of bias           
Studies with low risk of bias 10 6,511 -0.13 -0.18, -0.07 79.1 
Studies with potential risk of bias 1 27 -0.65 -0.87, -0.43 — 
Positive correlates – Doping intentionsb      
Publication status      
Published datasets 9 5,411 0.49 0.40, 0.59 92.6 
Unpublished datasets 6 2,464 0.31 0.24, 0.39 68.9 
Study design      
Cross-sectional studies 12 5,946 0.40 0.31, 0.48 92.9 
Longitudinal studies 3 1,930 0.56 0.52, 0.61 36.4 
Sport type      
Team sports participants 1 241 0.70 0.64, 0.77 — 
Mixed team and individual sports participants 9 5,012 0.39 0.29, 0.49 92.6 
Negative correlates – Doping intentionsb      
Study design      
Cross-sectional studies 9 4,114 -0.21 -0.33, -0.10 95.1 
Longitudinal studies 2 1,705 -0.44 -0.45, -0.43 0.0 
Participant background      
Competitive athletes 4 2,157 -0.16 -0.29, -0.02 90.1 
Gym users 2 397 -0.62 -0.85, -0.40 91.7 
Note. Moderators found for effect sizes are shown in italics; results of subgroup meta-analyses that were found to be different are shown below 
the moderator. k = number of meta-analyzed studies; n = total number of participants; CI = confidence interval; — = not applicable; I2 = test of 
homogeneity (shown when k>1). aOdds ratios; bCorrelation coefficient.  
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Figure 1. PRISMA flow diagram. WADA = World Anti-Doping Agency. 
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Figure 2. Path diagram of a Theory of Planned Behavior model using meta-analyzed 
correlations (k = 22, n = 5,046). All paths are significant at p < 0.001. 
 
